Based on these results, when considering the addition of chemotherapy to MONO for older NSCLC patients with high PD-L1 TPS, it becomes critical to appropriately select patients with predictive factors for better efficacy, particularly in this older demographic. Here, CD274 is linked to non-small cell lung carcinoma.